Samsung Bioepis Is Latest To Move Ustekinumab Into Phase III

Joins A Slew Of Other Biosimilar Developers Jostling For Position On Stelara

 
• By David Wallace
  
Paper people odd one out
Samsung Bioepis has joined a large Phase III crowd on ustekinumab • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products